Literature DB >> 35922698

Outcomes of open transverse abdominis release for ventral hernias: a systematic review, meta-analysis and meta-regression of factors affecting them.

Bhavin B Vasavada1, Hardik Patel2.   

Abstract

OBJECTIVES: The primary objectives were to evaluate Surgical Site Occurrences (SSO) and Surgical Site Occurrences requiring procedural Intervention (SSOPI) after open transversus abdominis release and to study various factors affecting it. Secondary objectives were to evaluate Surgical Site Infections (SSI), recurrence rates and overall complications after transversus abdominis release (TAR) and the factors responsible for those.
METHODS: We searched PUBMED, SCOPUS and Cochrane databases with keywords "transversus abdominis release" or "TAR" OR "Surgical Site Occurrences" OR "posterior component separation AND "outcomes" as per PRISMA 2020 and MOOSE guidelines. Full texts and English literature studies were included, studies mentioning outcomes for open transversus abdominis release for ventral hernia were included and studies with robotic transversus abdominis release were excluded. Percentage occurrences of SSO, SSOPI, SSI, recurrence and overall complications after TAR were evaluated. Random effect meta-analysis with restricted maximum likelihood methods was used for meta-analysis. Heterogeneity was analysed using I2 statistics. Publication bias with eager's test and funnel plots. Meta0regression analysis was done to evaluate factors affecting the heterogeneity. JASP 0.16.2 software was used for meta-analysis.
RESULTS: Twenty-two studies including 5284 patients who underwent TAR for ventral hernia were included in systematic review and meta-analysis. Overall pooled SSO, SSOPI, Overall Complications, SSI and recurrence rates were 21.72% [95% C.I 17.18-26.27%], 9.82% [95% C.I 7.64 -12%], 33.34% [95% C.I. 27.43-39.26%], 9.13% [95% C.I. 6.41-11.84] and 1.6% [0.78-2.44], respectively. Heterogeneity was significant in all the analysis. Age (p < 0.001), sex (p < 0.001), BMI (p < 0.001),presence of comorbidities (p < 0.001), prior recurrence, defect size (p < 0.001) and current or past history of tobacco exposure were associated with SSO in multivariate meta-regression analysis. Defect size (p = 0.04) was associated with SSOPI. Age (p = 0.011), BMI (p = 0.013), comorbidities (p < 0.01), tobacco exposure (p = 0.018), prior recurrence (p < 0.01) and sex (p < 0.01) were associated with overall complications.
CONCLUSION: Open transversus abdominis release is associated with high rates of SSO, SSOPI, SSI and overall complications but recurrence rates are low. Various preoperative factors mentioned may be responsible for heterogeneity across studies.
© 2022. The Author(s), under exclusive licence to Springer-Verlag France SAS, part of Springer Nature.

Entities:  

Keywords:  Surgical site Occurrences requiring procedural interventions; Surgical site occurrences; Transverse abdominis release; Ventral hernia

Year:  2022        PMID: 35922698     DOI: 10.1007/s10029-022-02657-z

Source DB:  PubMed          Journal:  Hernia        ISSN: 1248-9204            Impact factor:   2.920


  4 in total

1.  Perioperative outcomes of the Geriatric Assessment and Medical Preoperative Screening (GrAMPS) program pilot for older hernia patients: does chronological age predict outcomes?

Authors:  Bradley S Kushner; Timothy Holden; Britta J Han; Julia Hamilton; Margaret Sehnert; Sara E Holden
Journal:  Surg Endosc       Date:  2021-11-29       Impact factor: 3.453

2.  Outcomes of posterior component separation with transversus abdominis release (TAR) in large and other complex ventral hernias: a single-surgeon experience.

Authors:  G Chatzimavroudis; G Kotoreni; I Kostakis; N Voloudakis; E Christoforidis; B Papaziogas
Journal:  Hernia       Date:  2021-10-19       Impact factor: 2.920

3.  The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.

Authors:  Matthew J Page; Joanne E McKenzie; Patrick M Bossuyt; Isabelle Boutron; Tammy C Hoffmann; Cynthia D Mulrow; Larissa Shamseer; Jennifer M Tetzlaff; Elie A Akl; Sue E Brennan; Roger Chou; Julie Glanville; Jeremy M Grimshaw; Asbjørn Hróbjartsson; Manoj M Lalu; Tianjing Li; Elizabeth W Loder; Evan Mayo-Wilson; Steve McDonald; Luke A McGuinness; Lesley A Stewart; James Thomas; Andrea C Tricco; Vivian A Welch; Penny Whiting; David Moher
Journal:  BMJ       Date:  2021-03-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.